A certified solution standard suitable for use in LC/MS or GC/MS synthetic cannabinoid testing applications including clinical toxicology, forensic analysis, and urine drug testing. MAM2201 is a hybrid of the synthetic cannabinoids JWH-122 and AM-2201. This drug has been identified in European synthetic cannabinoid blends.
For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.